Showing results (271-280 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|August 18, 2000
Assessing health utilities in schizophrenia. A feasibility studyL N Voruganti, A G Awad, L K Oyewumi, et al.Pharmacoeconomics|December 12, 2001
Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesiasR C Dodel, K Berger, W H OertelPharmacoeconomics|December 12, 2001
A cost-cost study comparing etanercept with infliximab in rheumatoid arthritisM J Nuijten, P Engelfriet, K Duijn, et al.Pharmacoeconomics|April 4, 2001
Quality-of-life assessment in comparative therapeutic trials and causal structure considerations in peripheral occlusive arterial diseaseP LehertPharmacoeconomics|April 4, 2001
Health-related quality of life (HR-QOL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approvalG Apolone, G De Carli, M Brunetti, et al.Pharmacoeconomics|September 11, 2001
Cost effectiveness of Becaplermin in the treatment of diabetic foot ulcers in four European countriesO Ghatnekar, U Persson, M Willis, et al.Pharmacoeconomics|November 7, 2000
Antiviral therapies for herpes zoster infections. Are they economically justifiable?K J Smith, M S RobertsPharmacoeconomics|August 18, 2000
Clinical and economic factors important to anaesthetic choice for day-case surgeryE I Eger, P F White, M S BogetzPharmacoeconomics|September 8, 2000
Healthcare costs of patients with heart failure treated with torasemide or furosemideK T Stroupe, M M Forthofer, D C Brater, et al.Pageof 335